Clinical Trials Directory

Trials / Completed

CompletedNCT05661474

Fitostimoline® Hydrogel Versus Saline Gauze Dressing in Diabetic Foot Ulcers

The Effects of Fitostimoline® Hydrogel Versus Saline Gauze Dressing in Patients With Diabetic Foot Ulcers: a Monocentric, Two-arm, Open-label, Randomized, Controlled Trial.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Federico II University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Diabetes Mellitus (DM) is one of the most widespread metabolic diseases and the alarming rise in its prevalence worldwide poses enormous challenges. The microvascular and macrovascular complications of DM heavy impact on longevity and quality of life, and in particular diabetic foot ulcers (DFUs) are among the ten top causes of worldwide disease burden and disability Essential components of the standard care, management, and treatment of DFUs are represented by health education, strict control of blood glucose and cardiovascular risk factors, offloading, local debridement, and adequate dressing. A wide variety of dressing is available, and these include basic contact dressings (low adherence dressings such as saline gauze, paraffin gauze or simple absorbent dressings) and advanced dressings (alginate, hydrogel, films, hydrocolloid, foam). It is important underline that due to lack of evidence from head-to-head randomized controlled trials (RCTs), the relative effects of any of these dressings in DFUs remain unclear. Consequently, so far clinical evidence supporting the choice for either hydrogel or saline gauze dressing, has been related mostly on clinician perception rather than high quality evidence. Here we evaluated the efficacy and safety of Fitostimoline® hydrogel dressing versus saline gauze dressing in patients with DFUs in a monocentric, two-arm, open-label, randomized, controlled trial.

Conditions

Interventions

TypeNameDescription
DRUGFitostimoline ® hydrogel groupTreatment of DFUs with Fitostimoline® hydrogel every day for 12 weeks.
DRUGSaline gauze groupTreatment of DFUs with saline gauze every day for 12 weeks.

Timeline

Start date
2021-02-01
Primary completion
2022-07-12
Completion
2022-12-12
First posted
2022-12-22
Last updated
2022-12-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05661474. Inclusion in this directory is not an endorsement.